PPP - Public Private Partnerships

H2020 – Iniciativa de Medicamentos Innovadores – IMI2 – Calls 18 & 19

H2020 – Iniciativa de Medicamentos Innovadores – IMI2 – Calls 18 & 19

Esta convocatoria tiene como objetivo promover el desarrollo de medicamentos del futuro, mejores y más seguros, mediante la formación de ambiciosas redes y asociaciones de expertos.

Los topics que se incluirán son los siguientes:

  • Central repository of digital pathology slides to support the development of artificial intelligence tools.
  • Health Outcomes Observatories – empower patients with tools to measure their outcomes in a standardised manner creating transparency of health outcomes.
  • Improving patient access, understanding and adherence to healthcare information: an integrated digital health information project.
  • Establishing international standards in the analysis of patient reported outcomes and health-related quality of life data in cancer clinical trials.
  • Accelerating research & development for advanced therapy medicinal products.
  • Supporting the development of chimeric antigen receptor T cells.
  • Restricted call to maximise impact of IMI2 JU objectives and scientific priorities.